News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Berk Gregory
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2022 |
4
| Berk Gregory (Director) has filed a Form 4 on GT Biopharma, Inc.
Txns:
| Granted 278,058 shares
@ $0 Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
02/14/2022 |
3
| Berk Gregory (Director) has filed a Form 3 on GT Biopharma, Inc. |
01/11/2017 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on Verastem, Inc. |
11/01/2016 |
4
| Berk Gregory (CHIEF MEDICAL OFFICER) has filed a Form 4 on Verastem, Inc. |
04/19/2016 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on Verastem, Inc.
Txns:
| Granted 370,000 options to buy
@ $1.51, valued at
$558.7k
|
|
04/19/2016 |
3
| Berk Gregory (Chief Medical Officer) has filed a Form 3 on Verastem, Inc. |
01/15/2014 |
4
| Berk Gregory (Chief Medical Officer) has filed a Form 4 on BIND Therapeutics, Inc
Txns:
| Granted 4,967 options to buy
@ $2.78, valued at
$13.8k
Granted 4,967 options to buy
@ $2.78, valued at
$13.8k
Disposed/sold 4,967 options to buy
@ $2.78, valued at
$13.8k
Disposed/sold 4,453 options to buy
@ $2.52, valued at
$11.2k
Disposed/sold 64,189 options to buy
@ $2.52, valued at
$161.8k
|
|
03/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|